Literature DB >> 28966463

Sinonasal and laryngeal sarcoidosis.

Hawa Edriss1, John Kelley1, Joshua Demke1.   

Abstract

Sarcoidosis is a chronic granulomatous inflammation of uncertain etiology that can involve any organ system in the body. Sinonasal and laryngeal involvement is rare, poorly understood, and difficult to diagnose. Additionally, the extent of the disease is variable, and the response to systemic corticosteroids is often poor. We report a case of a 55-year-old woman with prior cutaneous sarcoidosis who presented with chronic nasal congestion, difficulty breathing, dysphonia, and stridor, and biopsy of the nasal vestibule revealed noncaseating granulomatous inflammation.

Entities:  

Year:  2017        PMID: 28966463      PMCID: PMC5595393          DOI: 10.1080/08998280.2017.11930226

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  19 in total

Review 1.  Upper airway. 4: Sarcoidosis of the upper respiratory tract (SURT).

Authors:  Robert P Baughman; Elyse E Lower; Thomas Tami
Journal:  Thorax       Date:  2010-02       Impact factor: 9.139

Review 2.  Pulmonary sarcoidosis and corticosteroids.

Authors:  O P Sharma
Journal:  Am Rev Respir Dis       Date:  1993-06

3.  Nasal and sinus manifestations of sarcoidosis.

Authors:  J F Zeitlin; T A Tami; R Baughman; D Winget
Journal:  Am J Rhinol       Date:  2000 May-Jun

4.  Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung.

Authors:  H J Milburn; L W Poulter; A Dilmec; G M Cochrane; D M Kemeny
Journal:  Clin Exp Immunol       Date:  1997-04       Impact factor: 4.330

Review 5.  Sinonasal sarcoidosis: review and report of fifteen cases.

Authors:  Jean Jacques Braun; André Gentine; Gabrielle Pauli
Journal:  Laryngoscope       Date:  2004-11       Impact factor: 3.325

6.  Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Authors:  Robert P Baughman; Marjolein Drent; Mani Kavuru; Marc A Judson; Ulrich Costabel; Roland du Bois; Carlo Albera; Martin Brutsche; Gerald Davis; James F Donohue; Joachim Müller-Quernheim; Rozsa Schlenker-Herceg; Susan Flavin; Kim Hung Lo; Barry Oemar; Elliot S Barnathan
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

7.  Laryngeal sarcoidosis: report of 13 patients.

Authors:  H B Neel; T J McDonald
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 Jul-Aug       Impact factor: 1.547

8.  Sarcoidosis of the paranasal sinuses treated with hydroxychloroquine.

Authors:  S Hassid; G Choufani; S Saussez; M Dubois; I Salmon; A Soupart
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

9.  Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.

Authors:  M A Judson; R P Baughman; U Costabel; S Flavin; K H Lo; M S Kavuru; M Drent
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

10.  Spontaneous improvement of laryngeal sarcoidosis resistant to systemic corticosteroid administration.

Authors:  Kazuya Tsubouchi; Naoki Hamada; Kayo Ijichi; Toshiro Umezaki; Koichi Takayama; Yoichi Nakanishi
Journal:  Respirol Case Rep       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.